← Back to Search

Multinutrient Formula

Lightning Stick for Attention Deficit Hyperactivity Disorder (ADHD)

N/A
Waitlist Available
Led By Jeanette Johnstone, PhD
Research Sponsored by Oregon Health and Science University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up once, at baseline
Awards & highlights

Summary

This trial will test if it's possible to study the effects of a supplement using at-home blood and urine samples, as well as online questionnaires.

Eligible Conditions
  • Attention Deficit Hyperactivity Disorder (ADHD)

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 6
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 6 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Abbreviated Acceptability Rating Profile - 7 questions on a 6-point Likert scale
Feasibility measured by count of remaining Sticks
Secondary outcome measures
Acceptability measured by a 'yes' response to their preference of completing online remote study visits instead of in-person study visits
Acceptability measured by a 'yes' response to their preference of using the Tasso device instead of a lab-based blood draw
Acceptability measured by a 'yes' response to their preference of using the at-home dried urine sample collection method instead of a lab-based urine sample collection method
+4 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Lightning StickExperimental Treatment1 Intervention
Feasibility and acceptability
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
EmpowerPlus Lightning Sticks
2022
N/A
~20

Find a Location

Who is running the clinical trial?

Oregon Health and Science UniversityLead Sponsor
985 Previous Clinical Trials
7,385,704 Total Patients Enrolled
6 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
545 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
Jeanette Johnstone, PhDPrincipal InvestigatorOregon Health and Science University
2 Previous Clinical Trials
60 Total Patients Enrolled
2 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
60 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
~7 spots leftby Jul 2025